{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:21:10Z","timestamp":1761718870461,"version":"build-2065373602"},"reference-count":50,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:00:00Z","timestamp":1570838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"R\u00e9gion Pays de Loire","award":["MECASTEM"],"award-info":[{"award-number":["MECASTEM"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>For Huntington\u2019s disease (HD) cell-based therapy, the transplanted cells are required to be committed to a neuronal cell lineage, survive and maintain this phenotype to ensure their safe transplantation in the brain. We first investigated the role of RE-1 silencing transcription factor (REST) inhibition using siRNA in the GABAergic differentiation of marrow-isolated adult multilineage inducible (MIAMI) cells, a subpopulation of MSCs. We further combined these cells to laminin-coated poly(lactic-co-glycolic acid) PLGA pharmacologically active microcarriers (PAMs) delivering BDNF in a controlled fashion to stimulate the survival and maintain the differentiation of the cells. The PAMs\/cells complexes were then transplanted in an ex vivo model of HD. Using Sonic Hedgehog (SHH) and siREST, we obtained GABAergic progenitors\/neuronal-like cells, which were able to secrete HGF, SDF1 VEGFa and BDNF, of importance for HD. GABA-like progenitors adhered to PAMs increased their mRNA expression of NGF\/VEGFa as well as their secretion of PIGF-1, which can enhance reparative angiogenesis. In our ex vivo model of HD, they were successfully transplanted while attached to PAMs and were able to survive and maintain this GABAergic neuronal phenotype. Together, our results may pave the way for future research that could improve the success of cell-based therapy for HDs.<\/jats:p>","DOI":"10.3390\/pharmaceutics11100526","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T03:54:13Z","timestamp":1571025253000},"page":"526","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Combinatorial Cell and Drug Delivery Strategy for Huntington\u2019s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells"],"prefix":"10.3390","volume":"11","author":[{"given":"Emilie M.","family":"Andr\u00e9","sequence":"first","affiliation":[{"name":"CRCINA, UMR 1232, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, F-49933 Angers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan J.","family":"Delcroix","sequence":"additional","affiliation":[{"name":"Geriatric Research, Education, and Clinical Center, and Research Service, Bruce W. Carter Department of Veterans Affairs Medical Center, Miami, FL 33125, USA"},{"name":"College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33125, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikrishna","family":"Kandalam","sequence":"additional","affiliation":[{"name":"CRCINA, UMR 1232, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, F-49933 Angers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Sindji","sequence":"additional","affiliation":[{"name":"CRCINA, UMR 1232, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, F-49933 Angers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia N.","family":"Montero-Menei","sequence":"additional","affiliation":[{"name":"CRCINA, UMR 1232, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, F-49933 Angers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington\u2019s disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00415-009-5164-9","article-title":"The relationship between impairment of voluntary movements and cognitive impairment in Huntington\u2019s disease","volume":"256","author":"Roth","year":"2009","journal-title":"J. Neurol."},{"key":"ref_4","first-page":"217","article-title":"Huntington\u2019s Disease: The Past, Present, and future search for Disease Modifiers","volume":"86","author":"Clabough","year":"2013","journal-title":"Yale J. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/rme.15.25","article-title":"Developing stem cell therapies for juvenile and adult-onset Huntington\u2019s disease","volume":"10","author":"Fink","year":"2015","journal-title":"Regen. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2011.12.030","article-title":"Gene therapy for Huntington\u2019s disease","volume":"48","author":"Ramaswamy","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Snyder, B.R., Chiu, A.M., Prockop, D.J., and Chan, A.W.S. (2010). Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington\u2019s disease. PloS One, 5.","DOI":"10.1371\/journal.pone.0009347"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biomaterials.2010.10.041","article-title":"The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats","volume":"32","author":"Delcroix","year":"2011","journal-title":"Biomaterials"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biomaterials.2015.12.008","article-title":"Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington\u2019s disease","volume":"83","author":"Passirani","year":"2016","journal-title":"Biomaterials"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Emerich, D.F., Cain, C.K., Greco, C., Saydoff, J.A., HU, Z.Y., Liu, H., and Lindner, M.D. (1997). Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington\u2019s disease. Cell Transplant., 249\u2013266.","DOI":"10.1177\/096368979700600308"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Hailong, L., Shanshan, H., Tan, H., Zhang, Y., and Li, H. (2011). Bone marrow mesenchymal stem cells can improve the motor function of a Huntington\u2019s disease rat model. Neurol. Res., 331\u2013337.","DOI":"10.1179\/016164110X12816242542571"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.3892\/mmr.2017.7069","article-title":"Comparison of the neuronal differentiation abilities of bone marrow-derived and adipose tissue-derived mesenchymal stem cells","volume":"16","author":"Zheng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.conb.2005.08.015","article-title":"The many faces of REST oversee epigenetic programming of neuronal genes","volume":"15","author":"Ballas","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2005.03.013","article-title":"REST and Its Corepressors Mediate Plasticity of Neuronal Gene Chromatin throughout Neurogenesis","volume":"121","author":"Ballas","year":"2005","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.yexcr.2008.04.008","article-title":"NRSF silencing induces neuronal differentiation of human mesenchymal stem cells","volume":"314","author":"Yang","year":"2008","journal-title":"Exp. Cell Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/2431","article-title":"NRSF\/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis","volume":"20","author":"Chen","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A novel phase inversion-based process for the preparation of lipid nanocarriers","volume":"19","author":"Heurtault","year":"2002","journal-title":"Pharm. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biomaterials.2009.09.044","article-title":"Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting","volume":"31","author":"Morille","year":"2010","journal-title":"Biomaterials"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1016\/j.biomaterials.2010.06.024","article-title":"The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability","volume":"31","author":"Paillard","year":"2010","journal-title":"Biomaterials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1242\/jcs.01103","article-title":"Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential","volume":"117","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2011.12.041","article-title":"Comparative analysis of protein expression of three stem cell populations: Models of cytokine delivery system in vivo","volume":"440","author":"Roche","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.5966\/sctm.2014-0139","article-title":"Survival, Differentiation, and Neuroprotective Mechanisms of Human Stem Cells Complexed With Neurotrophin-3-Releasing Pharmacologically Active Microcarriers in an Ex Vivo Model of Parkinson\u2019s Disease","volume":"4","author":"Daviaud","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diff.2010.07.001","article-title":"EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells","volume":"80","author":"Delcroix","year":"2010","journal-title":"Differentiation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1471-4159.2011.07272.x","article-title":"Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers: BMMs enhance MIAMI cell protection in cerebral ischemia","volume":"119","author":"Garbayo","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bone.2006.09.013","article-title":"Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons","volume":"40","author":"Tatard","year":"2007","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.biomaterials.2006.12.021","article-title":"Pharmacologically active microcarriers releasing glial cell line\u2014derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats","volume":"28","author":"Tatard","year":"2007","journal-title":"Biomaterials"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3727\/000000004783983675","article-title":"Montero-Menei CN In vivo evaluation of pharmacologically active microcarriers releasing nerve growth factor and conveying PC12 cells","volume":"13","year":"2004","journal-title":"Cell Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2013.04.017","article-title":"New PLGA-P188-PLGA matrix enhances TGF-\u03b23 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells","volume":"170","author":"Morille","year":"2013","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/jbm.a.35304","article-title":"Adipose-derived stem cell adhesion on laminin-coated microcarriers improves commitment toward the cardiomyogenic lineage","volume":"103","author":"Karam","year":"2015","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.actbio.2016.11.030","article-title":"Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural\/neuronal differentiation guidance and therapeutic secretome enhancement","volume":"49","author":"Kandalam","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2014.00254","article-title":"BDNF signaling and survival of striatal neurons","volume":"8","author":"Baydyuk","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington\u2019s Disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/gt.2008.23","article-title":"AAV\u2013BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment","volume":"15","author":"Kells","year":"2008","journal-title":"Gene Ther."},{"key":"ref_36","first-page":"501","article-title":"Expression pattern of PAX3 and PAX6 genes during human embryogenesis","volume":"43","year":"1999","journal-title":"Int. J. Dev. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1242\/dev.00166","article-title":"The early topography of thalamocortical projections is shifted in Ebf1 and Dlx1\/2 mutant mice","volume":"129","author":"Garel","year":"2002","journal-title":"Development"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2015.11.020","article-title":"Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy","volume":"497","author":"Andre","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Andr\u00e9, E.M., Daviaud, N., Sindji, L., Cayon, J., Perrot, R., and Montero-Menei, C.N. (2018). A novel ex vivo Huntington\u2019s disease model for studying GABAergic neurons and cell grafts by laser microdissection. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193409"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/biot.201400162","article-title":"Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma","volume":"9","author":"Resnier","year":"2014","journal-title":"Biotechnol. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1073\/pnas.0808488105","article-title":"Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats","volume":"105","author":"Aubry","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","article-title":"Human Embryonic Stem Cell-Derived GABA Neurons Correct Locomotion Deficits in Quinolinic Acid-Lesioned Mice","volume":"10","author":"Ma","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1523\/JNEUROSCI.18-04-01280.1998","article-title":"Neuronal expression of zinc finger transcription factor REST\/NRSF\/XBR gene","volume":"18","author":"Palm","year":"1998","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2009.10.158","article-title":"Laminin-1 induces neurite outgrowth in human mesenchymal stem cells in serum\/differentiation factors-free conditions through activation of FAK-MEK\/ERK signaling pathways","volume":"391","author":"Mruthyunjaya","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jnr.21358","article-title":"Enhanced neuronal differentiation in a three-dimensional collagen-hyaluronan matrix","volume":"85","author":"Bergman","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1523\/JNEUROSCI.1677-08.2008","article-title":"The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2567.2001.01292.x","article-title":"Enhancement of stromal cell-derived factor-1alpha-induced chemotaxis for CD4\/8 double-positive thymocytes by fibronectin and laminin in mice","volume":"104","author":"Yanagawa","year":"2001","journal-title":"Immunology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11946","DOI":"10.1073\/pnas.182296499","article-title":"Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","article-title":"Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders","volume":"979","author":"Luttun","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0366-6999.174496","article-title":"Nerve Growth Factor Promotes Angiogenesis and Skeletal Muscle Fiber Remodeling in a Murine Model of Hindlimb Ischemia","volume":"129","author":"Diao","year":"2016","journal-title":"Chin. Med. J. (Engl.)"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/10\/526\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:36Z","timestamp":1760189136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/10\/526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,12]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["pharmaceutics11100526"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics11100526","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2019,10,12]]}}}